2022 ICD-10-CM Diagnosis Code D75. 83: Thrombocytosis.Oct 1, 2021
Other specified abnormal findings of blood chemistryICD-10 code R79. 89 for Other specified abnormal findings of blood chemistry is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-10 | Thrombocytopenia, unspecified (D69. 6)
Abnormal finding of blood chemistry, unspecified R79. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R79. 9 became effective on October 1, 2021.
ICD-10 | Other fatigue (R53. 83)
Encounter for screening for other metabolic disorders 228 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z13. 228 became effective on October 1, 2021.
6: Thrombocytopenia, unspecified.
Thrombocytopenia is a condition in which you have a low blood platelet count. Platelets (thrombocytes) are colorless blood cells that help blood clot.
Doctors can diagnose pancytopenia with a complete blood count (CBC), a type of blood test that measures the levels of each blood cell type. Healthcare professionals may also make a peripheral blood smear by placing some blood on a slide and examining it under a microscope.
From ICD-10: For encounters for routine laboratory/radiology testing in the absence of any signs, symptoms, or associated diagnosis, assign Z01. 89, Encounter for other specified special examinations.Feb 24, 2022
005009: Complete Blood Count (CBC) With Differential | Labcorp.
A complete blood count consists of measuring a blood specimen for levels of hemoglobin, hematocrit, red blood cells, white blood cells, and platelets.
A chronic myeloproliferative neoplasm that involves primarily the megakaryocytic lineage. It is characterized by sustained thrombocytosis in the blood, increased numbers of large, mature megakaryocytes in the bone marrow, and episodes of thrombosis and/or hemorrhage. The cause is unknown.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
Functional activity. All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology]